Advanced search
Publication Cover
Climacteric Volume 16, 2013 - Issue 6
Submit an article Journal homepage
399
Views
18
CrossRef citations to date
0
Altmetric
Research Article

The safety of postoperative hormone replacement therapy in epithelial ovarian cancer patients in China

Y. WenDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
,
H. HuangDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
,
H. HuangDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
,
M. WuDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
,
K. ShenDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
&
L. PanDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China
Pages 673-681 | Received 15 Apr 2013, Accepted 14 May 2013, Published online: 30 Jul 2013

References

  • MacLennan AH. HRT in difficult circumstances: are there any absolute contraindications?Climacteric 2011;14:409–17
  • Elit L, Esplen MJ, Butler K, Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer 2001;1:149–56
  • Madalinska JB, Hollenstein J, Bleiker E, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 2005;23:6890–8
  • Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA. Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril 2006;85:1432–40
  • Salehi F, Dunfield L, Phillips KP, Krewski D, Vanderhyden BC. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev 2008;11:301–21
  • Plaxe SC, Braly PS, Freddo JL, McClay E, Kirmani S, Howell SB. Profiles of women age 30–39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol 1993;81:651–4
  • Rodriguez M, Nguyen HN, Averette HE, et al. National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer 1994;73:1245–50
  • Duska LR, Chang YC, Flynn CE, et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999;85: 2623–9
  • Pouilles JM, Tremollieres F, Bonneu M, Ribot C. Influence of early age at menopause on vertebral bone mass. J Bone Miner Res 1994;9:311–15
  • Voort DJ, Weijer PH, Barentsen R. Early menopause: increased fracture risk at older age. Osteoporos Int 2003;14:525–30
  • Farquhar D. Postmenopausal hormone replacement therapy for chronic disease prevention: results from the Women’s Health Initiative trial. CMAJ 2002;167:377–8
  • Wren B. Hormonal therapy and genital tract cancer. Curr Opin Obstet Gynecol 1996;8:38–41
  • Richardson GS. Endometrial cancer as an estrogen-progesterone target. N Engl J Med 1972;286:645–7
  • Weiss NS, Szekely DR, English DR, Schweid AI. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA 1979;242:261–4
  • Fasching PA, Ekici AB, Adamietz B, et al. Breast cancer risk – genes, environment, and clinical practice. Geburtsh Frauenheilk 2011;71:1056–66
  • Kummel S, Kolberg HC, Luftner D, et al. Breast cancer 2011 – new aspects. Geburtsh Frauenheilk 2011;71:939–53
  • Hein A, Thiel FC, Bayer CM, et al. Hormone replacement therapy and prognosis in ovarian cancer patients. Eur J Cancer Prev 2012;22:52–8
  • Biliatis I, Thomakos N, Rodolakis A, et al. Safety of hormone replacement therapy in gynaecological cancer survivors. J Obstet Gynaecol 2012;32:321–5
  • Ursic-Vrscaj M, Bebar S, Zakelj MP. Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. Menopause 2001;8:70–5
  • Bendel RB, Afifi AA. Comparison of stopping rules in forward regression. J Am Stat Assoc 1977;72:46–53
  • Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses’ Health Study. Obstet Gynecol 2009;113: 1027–37
  • Shuster LT, Rhodes DJ, Gostout BS, et al. Premature menopause or early menopause: long term health consequences. Maturitas 2010;65:161–6
  • Teede HJ, Vincent A. Hormone therapy – where are we now?Aust Fam Physician 2011;40:280–5
  • Beral V; Million Women Study Collaborators, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369: 1703–10
  • Coughlin SS, Giustozzi A, Smith SJ, Lee NC. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol 2000;53:367–75
  • Eeles RA, Tan S, Wiltshaw E, et al. Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ 1991; 302:259–62
  • Ho SM. Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 2003;1:73
  • Guidozzi F, Daponte A. Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial. Cancer 1999;86:1013–18
  • Garg PP, Kerlikowske K, Subak L, Grady D. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998;92:472–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.